Kidney Histopathology of Patients with Hepatitis C Infection and Diabetes Mellitus before and after Availability of Direct-Acting Antiviral Therapy
Introduction: Type 2 diabetes mellitus (DM) and diabetic kidney disease are increasing. Hepatitis C infection (HCV) occurs in 1% of the world population and can induce several kidney diseases. DM prevalence is increased in individuals with HCV; however, kidney diseases in those with both DM and HCV...
Main Authors: | Vanderlene L. Kung, Gabriel Giannini, Cynthia C. Nast |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2024-03-01
|
Series: | Glomerular Diseases |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/537977 |
Similar Items
-
Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report
by: Michiko Shimada, et al.
Published: (2017-03-01) -
New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01) -
Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
by: Soon Young Ko, et al.
Published: (2018-12-01) -
Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence
by: Fabrizio Fabrizi, et al.
Published: (2019-10-01) -
Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals
by: Erica Nicola Lynch, et al.
Published: (2023-03-01)